In recent trading session, Chemours Company (NYSE:CC) saw 0.43 million shares changing hands at last check today with its beta currently measuring 1.63. Company’s recent per share price level of $11.88 trading at $0.48 or 4.21% at last check today assigns it a market valuation of $1.78B. That most recent trading price of CC’s stock is at a discount of -114.98% from its 52-week high price of $25.54 and is indicating a premium of 23.15% from its 52-week low price of $9.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.55 million shares which gives us an average trading volume of 3.64 million if we extend that period to 3-months.
For Chemours Company (CC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 10 see the stock as a Buy. 1 analyst(s) advised it as an Underweight.
Chemours Company (NYSE:CC) trade information
Upright in the green today for gaining 4.21%, in the last five days CC remained trading in the green while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $11.88 price level, subtracting -0.68% to its value on the day. Chemours Company’s shares saw a change of -48.97% in year-to-date performance and have moved 8.00% in past 5-day. Chemours Company (NYSE:CC) showed a performance of 11.86% in past 30-days. Number of shares sold short was 14.33 million shares which calculate 3.53 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 16 to the stock, which implies a rise of 25.75% to its recent value today. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 17. It follows that stock’s current price would drop -26.26% in reaching the projected high whereas dropping to the targeted low would mean a loss of -26.26% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 32.80% while estimates for its earnings growth in next 5 years are of 33.00%.
CC Dividends
Chemours Company is more likely to be releasing its next quarterly report on 2025-May-06 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 7.05%, the share has a forward dividend of 0.84 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 4.04%.
Chemours Company (NYSE:CC)’s Major holders
Insiders are in possession of 0.46% of company’s total shares while institution are holding 98.02 percent of that, with stock having share float percentage of 98.47%. Investors also watch the number of corporate investors in a company very closely, which is 98.02% institutions for Chemours Company that are currently holding shares of the company. FMR LLC is the top institutional holder at CC for having 17.52 million shares of worth $395.51 million. And as of 2024-06-30, it was holding 11.7284 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 16.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.8823 of outstanding shares, having a total worth of $366.98 million.
